Analysen zu Novo Nordisk
| 24.02.25 | Novo Nordisk Buy | UBS AG | |
| 20.02.25 | Novo Nordisk Market-Perform | Bernstein Research | |
| 19.02.25 | Novo Nordisk Buy | Goldman Sachs Group Inc. | |
| 17.02.25 | Novo Nordisk Buy | UBS AG | |
| 17.02.25 | Novo Nordisk Buy | Deutsche Bank AG | |
| 12.02.25 | Novo Nordisk Buy | Deutsche Bank AG | |
| 11.02.25 | Novo Nordisk Market-Perform | Bernstein Research | |
| 11.02.25 | Novo Nordisk Buy | Deutsche Bank AG | |
| 10.02.25 | Novo Nordisk Buy | UBS AG | |
| 10.02.25 | Novo Nordisk Buy | Deutsche Bank AG | |
| 10.02.25 | Novo Nordisk Buy | Goldman Sachs Group Inc. | |
| 07.02.25 | Novo Nordisk Buy | UBS AG | |
| 06.02.25 | Novo Nordisk Halten | DZ BANK | |
| 06.02.25 | Novo Nordisk Buy | Deutsche Bank AG | |
| 06.02.25 | Novo Nordisk Buy | UBS AG | |
| 06.02.25 | Novo Nordisk Overweight | JP Morgan Chase & Co. | |
| 05.02.25 | Novo Nordisk Market-Perform | Bernstein Research | |
| 05.02.25 | Novo Nordisk Buy | UBS AG | |
| 05.02.25 | Novo Nordisk Buy | Goldman Sachs Group Inc. | |
| 05.02.25 | Novo Nordisk Overweight | JP Morgan Chase & Co. | |
| 05.02.25 | Novo Nordisk Underperform | Jefferies & Company Inc. | |
| 03.02.25 | Novo Nordisk Buy | UBS AG | |
| 29.01.25 | Novo Nordisk Buy | UBS AG | |
| 29.01.25 | Novo Nordisk Overweight | JP Morgan Chase & Co. | |
| 28.01.25 | Novo Nordisk Buy | UBS AG | |
| 27.01.25 | Novo Nordisk Buy | Deutsche Bank AG | |
| 24.01.25 | Novo Nordisk Buy | UBS AG | |
| 24.01.25 | Novo Nordisk Buy | Goldman Sachs Group Inc. | |
| 24.01.25 | Novo Nordisk Overweight | JP Morgan Chase & Co. | |
| 24.01.25 | Novo Nordisk Underperform | Jefferies & Company Inc. | |
| 21.01.25 | Novo Nordisk Buy | UBS AG | |
| 17.01.25 | Novo Nordisk Market-Perform | Bernstein Research | |
| 17.01.25 | Novo Nordisk Overweight | JP Morgan Chase & Co. | |
| 17.01.25 | Novo Nordisk Buy | UBS AG | |
| 16.01.25 | Novo Nordisk Buy | UBS AG | |
| 15.01.25 | Novo Nordisk Market-Perform | Bernstein Research | |
| 13.01.25 | Novo Nordisk Buy | UBS AG | |
| 10.01.25 | Novo Nordisk Buy | Goldman Sachs Group Inc. | |
| 10.01.25 | Novo Nordisk Buy | Deutsche Bank AG | |
| 08.01.25 | Novo Nordisk Buy | UBS AG | |
| 07.01.25 | Novo Nordisk Hold | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 06.01.25 | Novo Nordisk Market-Perform | Bernstein Research | |
| 06.01.25 | Novo Nordisk Overweight | JP Morgan Chase & Co. | |
| 06.01.25 | Novo Nordisk Buy | Deutsche Bank AG | |
| 06.01.25 | Novo Nordisk Hold | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 06.01.25 | Novo Nordisk Underperform | Jefferies & Company Inc. | |
| 23.12.24 | Novo Nordisk Overweight | Barclays Capital | |
| 23.12.24 | Novo Nordisk Halten | DZ BANK | |
| 20.12.24 | Novo Nordisk Underperform | Bernstein Research | |
| 20.12.24 | Novo Nordisk Neutral | UBS AG |
Aktuelle Aktienanalysen
| 29.01.26 | ING Group Buy | UBS AG | |
| 29.01.26 | SAP Buy | UBS AG | |
| 29.01.26 | Nordea Bank Abp Registered Shs Buy | Jefferies & Company Inc. | |
| 29.01.26 | Givaudan Buy | Jefferies & Company Inc. | |
| 29.01.26 | Roche Underperform | Jefferies & Company Inc. | |
| 29.01.26 | Sanofi Buy | Jefferies & Company Inc. | |
| 29.01.26 | ING Group Hold | Jefferies & Company Inc. | |
| 29.01.26 | Hennes & Mauritz AB Hold | Jefferies & Company Inc. | |
| 29.01.26 | ABB Hold | Jefferies & Company Inc. | |
| 29.01.26 | Nokia Buy | Jefferies & Company Inc. | |
| 29.01.26 | DWS Group Hold | Jefferies & Company Inc. | |
| 29.01.26 | Deutsche Bank Hold | Jefferies & Company Inc. | |
| 29.01.26 | ASML NV Outperform | Bernstein Research | |
| 29.01.26 | SAP Buy | Jefferies & Company Inc. | |
| 29.01.26 | LVMH Moet Hennessy Louis Vuitton Hold | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 29.01.26 | STMicroelectronics Buy | Jefferies & Company Inc. | |
| 29.01.26 | Deutsche Bank Overweight | JP Morgan Chase & Co. | |
| 29.01.26 | Deutsche Bank Hold | Warburg Research | |
| 29.01.26 | Microsoft Outperform | RBC Capital Markets | |
| 29.01.26 | Deutsche Bank Outperform | RBC Capital Markets | |
| 29.01.26 | ASML NV Overweight | JP Morgan Chase & Co. | |
| 29.01.26 | ASML NV Buy | Goldman Sachs Group Inc. | |
| 29.01.26 | Meta Platforms Buy | UBS AG | |
| 29.01.26 | SAP Buy | Goldman Sachs Group Inc. | |
| 29.01.26 | ASML NV Overweight | Barclays Capital | |
| 29.01.26 | SAP Overweight | JP Morgan Chase & Co. | |
| 29.01.26 | Volvo AB Overweight | JP Morgan Chase & Co. | |
| 29.01.26 | Fresenius Overweight | JP Morgan Chase & Co. | |
| 29.01.26 | London Stock Exchange Overweight | JP Morgan Chase & Co. | |
| 29.01.26 | ASML NV Buy | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 29.01.26 | ATOSS Software Buy | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 29.01.26 | Tesla Hold | Jefferies & Company Inc. | |
| 29.01.26 | ArcelorMittal Overweight | JP Morgan Chase & Co. | |
| 29.01.26 | Salzgitter Underweight | JP Morgan Chase & Co. | |
| 29.01.26 | thyssenkrupp Neutral | JP Morgan Chase & Co. | |
| 29.01.26 | Tesla Outperform | RBC Capital Markets | |
| 29.01.26 | Meta Platforms Outperform | RBC Capital Markets | |
| 28.01.26 | ASML NV Hold | Jefferies & Company Inc. | |
| 28.01.26 | Continental Buy | Jefferies & Company Inc. | |
| 28.01.26 | DWS Group Hold | Jefferies & Company Inc. | |
| 28.01.26 | DWS Group Outperform | RBC Capital Markets | |
| 28.01.26 | Airbus Outperform | RBC Capital Markets | |
| 28.01.26 | Continental Overweight | JP Morgan Chase & Co. | |
| 28.01.26 | LVMH Moet Hennessy Louis Vuitton Kaufen | DZ BANK | |
| 28.01.26 | ASML NV Halten | DZ BANK | |
| 28.01.26 | WACKER CHEMIE Verkaufen | DZ BANK | |
| 28.01.26 | Eni Buy | Jefferies & Company Inc. | |
| 28.01.26 | AstraZeneca Overweight | JP Morgan Chase & Co. | |
| 28.01.26 | Boeing Buy | Goldman Sachs Group Inc. | |
| 28.01.26 | Intel Market-Perform | Bernstein Research |
ETF-Sparplan
Oskar ist der einfache und intelligente ETF-Sparplan. Er übernimmt die ETF-Auswahl, ist steuersmart, transparent und kostengünstig.